# Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis

> **NCT02515799** · PHASE4 · COMPLETED · sponsor: **bene-Arzneimittel GmbH** · enrollment: 27 (actual)

## Conditions studied

- Bronchitis, Chronic
- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Tacholiquine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02515799
- **Lead sponsor:** bene-Arzneimittel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-07
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02515799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02515799, "Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02515799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*